Dr. Elena Voss
CEO & Co-Founder
Formerly a computational structural biologist at a Baltimore-area academic medical center. PhD in biophysics; 8 years building PPI structure-activity models before founding Genolux.
People
The Team
Computational biologists, medicinal chemists, and oncology biologists building purpose-built PPI modeling tools.
Dr. Marcus Hale
Principal Computational Chemist & Co-Founder
Medicinal chemistry background with deep expertise in fragment-based lead discovery and PPI-focused library design. Previously worked on oncology programs at an independent biotech.
Dr. Ravi Sundaram
Director, Computational Biology
Structural bioinformatics specialist with expertise in Rosetta interface scoring, protein complex analysis, and large-scale molecular dynamics simulation pipelines.
Dr. Natasha Okonkwo
Head, Oncology Biology
Cell biology and oncology focus — translates computational predictions into testable cellular hypotheses, ensuring modeling work connects to biologically meaningful outcomes.
Scientific Advisors
Advisory Board
Scientific Advisor — Structural Biology
Professor of Structural Biology at a US research university. Research focus on macromolecular complex assembly and PPI interface thermodynamics. Advises on experimental validation strategy and benchmarking methodology.
Scientific Advisor — Oncology Drug Development
Industry advisor with 20 years of oncology drug development experience, including IND-enabling and clinical-stage programs for PPI-targeting compounds. Advises on program prioritization and partnering strategy.
Scientific Advisor — Computational Chemistry
Computational chemistry lead at a mid-size biotech, specializing in fragment-based drug design and hit-to-lead optimization. Advises on library design and virtual screening workflow integration.
Join the Team
We are hiring computational biologists and research software engineers who care deeply about PPI drug discovery.